Author

A. Saber

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

B. Liu· 1 shared D. Chen· 1 shared H. J. Haisma· 1 shared S. Chen· 1 shared

Activity by Year

2019-2019 · peak 1/yr

Co-Author Collaboration Network

4 top collaborators · 6 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

B. Liu

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivNov 21, 2019

Transcriptional activation of cyclin D1 via HER2/HER3 contributes to cell survival and EGFR tyrosine kinase inhibitor resistance in non-small cell lung carcinoma

B. Liu, D. Chen, S. Chen…·H. J. Haisma

The paper investigates mechanisms of EGFR-TKI resistance in NSCLC, showing HER2/HER3 activation and cyclin D1 upregulation contribute to cell survival and resistance.

DOI 10.1016/j.bcp.2020.114095

humanbulk RNA-seq

𝕏 PostBluesky